greeksoup/ stock research

National Healthcare (NHC) FY2022 results: revenue $1.1 billion, up 1.1% on the year

National Healthcare Corp. (NHC) reported revenue of $1.1 billion for fiscal 2022, the year ended 31 December 2022, up 1.1% on the year before. Net income was $22 million, down 83.8%, and diluted earnings per share $1.45. The figures are the company's own, from the 10-K it filed with the SEC on 17 February 2023.

Revenue
$1.1 billion
+1.1% on the year
FY2016FY2022
Operating margin
2.9%
4.7% a year earlier
FY2016FY2022
Net income
$22 million
-83.8% on the year
FY2016FY2022
Diluted EPS
$1.45
-83.9% on the year
FY2016FY2022

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2022 · Q2 FY2022 · Q3 FY2022 · Q4 FY2022

Income statement (profit and loss)

$ millionFY2022FY2021FY2020On the yearLast 8 years
Revenue1,0861,0741,028+1.1%
Operating income31.950.948.2-37.4%
Operating margin2.9%4.7%4.7%
Interest expense0.60.81.4-33.4%
Pre-tax income27.2n/an/a
Income tax7.311.010.4-33.8%
Effective tax rate26.6%n/an/a
Net income22.413941.9-83.8%
Net margin2.1%12.9%4.1%
Diluted EPS$1.45$8.99$2.72-83.9%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2022FY2021FY2020On the yearLast 8 years
Operating cash flow8.762.4203-86.0%
Capital expenditure30.239.421.9-23.3%
Free cash flow-21.523.0181
Free cash flow margin-2.0%2.1%17.6%
Cash from investing-6.0-65.9-63.9
Cash from financing-47.6-35.3-41.9
Depreciation and amortisation40.540.742.0-0.4%
Share-based compensation2.62.62.5-0.3%
Buybacks9.90.80.1+1,084.6%
Dividends paid34.632.031.9+8.0%
Dividend per share$2.26$2.11$2.08+7.1%
Diluted shares, weighted15m15m15m+0.2%
Shares outstanding at period end15m15m15m-0.6%

Balance sheet

$ millionFY2022FY2021FY2020On the yearLast 8 years
Shareholders' equity874903795-3.2%
Non-controlling interest3.25.53.1-40.7%
Debt0.00.00.0
Operating lease liabilities91.0129154-29.2%
Finance lease liabilities0.95.810.5-85.3%
Other liabilities306361400-15.1%
Total liabilities and equity1,2751,4031,362-9.1%
Fixed assets507521520-2.8%
Goodwill16816821.30.0%
Intangible assets7.07.00.00.0%
Securities held for sale or to maturity143172190-17.1%
Cash and equivalents58.7108147-45.5%
Receivables100.096.189.7+4.0%
Inventory7.18.68.8-17.4%
Other assets285323385-11.6%
Total assets1,2751,4031,362-9.1%

10-K for the year ended 31 December 2022, filed 17 February 2023: the filing.